HK1206731A1 - Method for preparing substituted triazolopyridines - Google Patents

Method for preparing substituted triazolopyridines

Info

Publication number
HK1206731A1
HK1206731A1 HK15107242.4A HK15107242A HK1206731A1 HK 1206731 A1 HK1206731 A1 HK 1206731A1 HK 15107242 A HK15107242 A HK 15107242A HK 1206731 A1 HK1206731 A1 HK 1206731A1
Authority
HK
Hong Kong
Prior art keywords
preparing substituted
substituted triazolopyridines
triazolopyridines
preparing
substituted
Prior art date
Application number
HK15107242.4A
Other languages
English (en)
Chinese (zh)
Inventor
Volker Schulze
Franz-Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of HK1206731A1 publication Critical patent/HK1206731A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15107242.4A 2012-07-10 2015-07-29 Method for preparing substituted triazolopyridines HK1206731A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
HK1206731A1 true HK1206731A1 (en) 2016-01-15

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107242.4A HK1206731A1 (en) 2012-07-10 2015-07-29 Method for preparing substituted triazolopyridines

Country Status (24)

Country Link
US (1) US9388177B2 (he)
EP (1) EP2872506A1 (he)
JP (1) JP6238979B2 (he)
KR (1) KR20150040845A (he)
CN (1) CN104603136B (he)
AP (1) AP3778A (he)
AU (1) AU2013289381A1 (he)
BR (1) BR112015000308A2 (he)
CA (1) CA2878481A1 (he)
CL (1) CL2015000038A1 (he)
CO (1) CO7160002A2 (he)
CR (1) CR20150006A (he)
DO (1) DOP2015000007A (he)
EA (1) EA027544B1 (he)
HK (1) HK1206731A1 (he)
IL (1) IL236265A (he)
IN (1) IN2015DN00085A (he)
MX (1) MX2015000348A (he)
NZ (1) NZ703020A (he)
PE (1) PE20150354A1 (he)
PH (1) PH12015500061A1 (he)
SG (1) SG11201408419QA (he)
TN (1) TN2015000008A1 (he)
WO (1) WO2014009219A1 (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2914521A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
CN105377848A (zh) * 2013-06-11 2016-03-02 拜耳制药股份公司 取代的三唑并吡啶的前体药物衍生物
EA201600003A1 (ru) 2013-06-11 2016-06-30 Байер Фарма Акциенгезельшафт КОМБИНАЦИИ ДЛЯ ЛЕЧЕНИЯ РАКА, СОДЕРЖАЩИЕ ИНГИБИТОР Mps-1 КИНАЗЫ И ИНГИБИТОР МИТОЗА
ES2966392T3 (es) 2015-04-17 2024-04-22 Crossfire Oncology Holding B V Biomarcadores pronósticos para quimioterapia inhibidora de TTK
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003030937A1 (ja) * 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
JP2007537296A (ja) * 2004-05-14 2007-12-20 アボット・ラボラトリーズ 治療薬としてのキナーゼ阻害薬
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
US7524860B2 (en) * 2004-10-07 2009-04-28 Pfizer Inc. Antibacterial agents
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
WO2007145921A1 (en) * 2006-06-06 2007-12-21 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
CN103641829A (zh) 2006-08-30 2014-03-19 塞尔佐姆有限公司 作为激酶抑制剂的三唑衍生物
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
JP2010533680A (ja) 2007-07-18 2010-10-28 ノバルティス アーゲー 二環ヘテロアリール化合物およびそれらのキナーゼ阻害剤としての使用
AU2008290330A1 (en) 2007-08-23 2009-02-26 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of TTK/Mps1 for the treatment of proliferative disorders
EA201070328A1 (ru) 2007-08-31 2010-08-30 Мерк Сероно С.А. Соединения триазолопиридина и их применение в качестве ингибиторов ask
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
WO2009155527A2 (en) * 2008-06-19 2009-12-23 Progenics Pharmaceuticals, Inc. Phosphatidylinositol 3 kinase inhibitors
JP2012517971A (ja) 2009-02-13 2012-08-09 フォーヴィア・ファーマシューティカルズ キナーゼ阻害薬としての［１，２，４］トリアゾロ［１，５−ａ］ピリジン類
JP6168773B2 (ja) 2009-04-29 2017-07-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 置換イミダゾキノキサリン
WO2010141796A2 (en) * 2009-06-05 2010-12-09 Cephalon, Inc. PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
US9340528B2 (en) 2009-09-04 2016-05-17 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
PT2699575E (pt) * 2011-04-21 2015-07-29 Bayer Ip Gmbh Triazolopiridinas
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
EP2872506A1 (en) 2015-05-20
CN104603136A (zh) 2015-05-06
AP2014008177A0 (en) 2014-12-31
US9388177B2 (en) 2016-07-12
EA201590116A1 (ru) 2015-07-30
CR20150006A (es) 2015-02-16
EA027544B1 (ru) 2017-08-31
MX2015000348A (es) 2015-04-14
IN2015DN00085A (he) 2015-05-29
IL236265A (he) 2017-07-31
WO2014009219A1 (en) 2014-01-16
BR112015000308A2 (pt) 2017-06-27
KR20150040845A (ko) 2015-04-15
JP2015523372A (ja) 2015-08-13
TN2015000008A1 (en) 2016-06-29
AU2013289381A1 (en) 2015-01-22
US20150148542A1 (en) 2015-05-28
PH12015500061A1 (en) 2015-03-02
DOP2015000007A (es) 2015-02-15
SG11201408419QA (en) 2015-01-29
CL2015000038A1 (es) 2015-03-13
IL236265A0 (he) 2015-02-26
CN104603136B (zh) 2017-06-27
AP3778A (en) 2016-08-31
NZ703020A (en) 2017-08-25
JP6238979B2 (ja) 2017-11-29
CO7160002A2 (es) 2015-01-15
CA2878481A1 (en) 2014-01-16
PE20150354A1 (es) 2015-03-21

Similar Documents

Publication Publication Date Title
ZA201501833B (en) Method for obtaining 1-kestone
GB201212937D0 (en) Method
GB201212932D0 (en) Method
GB201213636D0 (en) Method
GB201222693D0 (en) Novel method
EP2837628A4 (en) METHOD FOR PRODUCING A RIVAROXA INTERMEDIATE PRODUCT
GB201212934D0 (en) Method
GB201210858D0 (en) Method
EP2837619A4 (en) PROCESS FOR THE PRODUCTION OF BETA-ALCOXYPROPIONAMIDE
EP2707367A4 (en) PROCESS FOR THE PRODUCTION OF NAPHTHYRIDINES
EP2880048A4 (en) METHOD
HK1206731A1 (en) Method for preparing substituted triazolopyridines
EP2824130A4 (en) PROCESS FOR PRODUCING POLYDIALKYLSILANE
GB201202198D0 (en) Method
EP2855433A4 (en) PROCESS FOR THE PREPARATION OF DIHALOPYRIDINES
EP2819995A4 (en) PROCESS FOR THE PREPARATION OF 3-METHYLSULFONYLPROPIONITRIL
EP2818476A4 (en) PROCESS FOR PREPARING 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-L-FURANIDOSE
EP2915817A4 (en) PROCESS FOR THE PREPARATION OF EXENATIDE
SG11201501567QA (en) Method for producing 7-octenal
EP2816039A4 (en) PROCESS FOR PREPARING A LINEZOLIDE INTERMEDIATE
GB201211393D0 (en) Method
EP2840305A4 (en) METHOD OF PREPARING A REFLECTOR
GB201214029D0 (en) method
GB201210147D0 (en) Method
IL238934A (he) שיטות להכנת נגזרות פנילוקסימתיל–ניטרו–אימידאזול